Standard
The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. / Donath, Marc Y; Mandrup-Poulsen, Thomas.
In:
Nature Clinical Practice Endocrinology & Metabolism, Vol. 4, No. 5, 2008, p. 240-1.
Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
Donath, MY
& Mandrup-Poulsen, T 2008, '
The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.',
Nature Clinical Practice Endocrinology & Metabolism, vol. 4, no. 5, pp. 240-1.
https://doi.org/10.1038/ncpendmet0783APA
Donath, M. Y.
, & Mandrup-Poulsen, T. (2008).
The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nature Clinical Practice Endocrinology & Metabolism,
4(5), 240-1.
https://doi.org/10.1038/ncpendmet0783Vancouver
Donath MY
, Mandrup-Poulsen T.
The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. Nature Clinical Practice Endocrinology & Metabolism. 2008;4(5):240-1.
https://doi.org/10.1038/ncpendmet0783Author
Donath, Marc Y ; Mandrup-Poulsen, Thomas. / The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus. In: Nature Clinical Practice Endocrinology & Metabolism. 2008 ; Vol. 4, No. 5. pp. 240-1.
Bibtex
@article{d4fdd450acd111ddb538000ea68e967b,
title = "The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.",
abstract = "Udgivelsesdato: 2008-May",
author = "Donath, {Marc Y} and Thomas Mandrup-Poulsen",
note = "Keywords: Adipokines; C-Reactive Protein; Diabetes Mellitus, Type 2; Hemoglobin A, Glycosylated; Humans; Injections, Subcutaneous; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Proinsulin; Randomized Controlled Trials as Topic; Receptors, Interleukin-1",
year = "2008",
doi = "10.1038/ncpendmet0783",
language = "English",
volume = "4",
pages = "240--1",
journal = "Nature Reviews Endocrinology",
issn = "1759-5029",
publisher = "nature publishing group",
number = "5",
}
RIS
TY - JOUR
T1 - The use of interleukin-1-receptor antagonists in the treatment of diabetes mellitus.
AU - Donath, Marc Y
AU - Mandrup-Poulsen, Thomas
N1 - Keywords: Adipokines; C-Reactive Protein; Diabetes Mellitus, Type 2; Hemoglobin A, Glycosylated; Humans; Injections, Subcutaneous; Insulin; Insulin Resistance; Insulin-Secreting Cells; Interleukin 1 Receptor Antagonist Protein; Interleukin-6; Proinsulin; Randomized Controlled Trials as Topic; Receptors, Interleukin-1
PY - 2008
Y1 - 2008
N2 - Udgivelsesdato: 2008-May
AB - Udgivelsesdato: 2008-May
U2 - 10.1038/ncpendmet0783
DO - 10.1038/ncpendmet0783
M3 - Journal article
C2 - 18317479
VL - 4
SP - 240
EP - 241
JO - Nature Reviews Endocrinology
JF - Nature Reviews Endocrinology
SN - 1759-5029
IS - 5
ER -
